참고문헌
- Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS(2007). Spectrum of breast cancer in Asian women. World J Surg 31, 1031-40. https://doi.org/10.1007/s00268-005-0585-9
- Boice JD Jr, Preston D, Davis FG, Monson RR (1991). Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis. Radiat Res, 125, 214-22. https://doi.org/10.2307/3577890
- Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT(1992). Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med, 326, 781-85. https://doi.org/10.1056/NEJM199203193261201
- Chougule A (1999). Measurement of contra lateral breast doses due to primary irradiation of malignant breast. Ind J of clinical Radio Oncol, 7, 17-20.
- Committee to Assess Health Risks from Exposure to Low Level of Ionizing Radiation (2006). Health risks from exposure to low levels of ionizing radiation: BEIR VII, Phase 2 .Washington, D.C: National Academies Press.
- Cavey ML, Bayouth JE, Endres EJ, et al (2005).Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers . Med Dosim, 30, 107-16. https://doi.org/10.1016/j.meddos.2005.02.002
- Dinshaw KA, Sarin R, Budrukkar AN, et al (2006). Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial hospital. J Surg Oncol, 94, 105-13. https://doi.org/10.1002/jso.20497
- Dasu A, Dasu IT, Olofsson J, Karlsson M (2005).The use of risk estimation models for the induction of second cancers following radiotherapy. Acta Oncol, 44, 339-47. https://doi.org/10.1080/02841860510029833
- Dores GM, Metayer C, Curtis RE, et al (2002). Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol, 20, 3484-94. https://doi.org/10.1200/JCO.2002.09.038
- Gao X, Fisher SG, Emami B (2003). Risk of second primary cancer in the contralateral breast in women treated for earlystage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys, 56, 1038-45. https://doi.org/10.1016/S0360-3016(03)00203-7
- Harvey EB, Brinton LA (1985). Second cancer following cancer of breast in Connecticut,1935-82. J Natl Cancer Inst Monogr, 68, 99-112.
- Haffty BG, Harrold E, Khan AJ(2002).Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet, 359, 1471-77. https://doi.org/10.1016/S0140-6736(02)08434-9
- Hancock SL, Hoppe RT (1996). Long-term complications of treatment and causes of mortality after hodgkin's disease. Semin Radiat Oncol, 6, 225-42. https://doi.org/10.1016/S1053-4296(96)80018-X
- Johansen S, Danielsen T, Olsen DG (2008). Estimated risk for second cancer in the contra-lateral breast following radiation therapy of breast cancer. Acta Oncol, 47, 391-96. https://doi.org/10.1080/02841860701846152
- Morganti AG, Cilla S, Gaetano A, et al (2011). Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When?. J Appl Clin Med Phys, 12, 3451.
- Obedian E, Fischer DB, Haffty BG (2000). Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol, 18, 2406-12. https://doi.org/10.1200/JCO.2000.18.12.2406
- Preston DL, Ron E, Tokuoka S, et al (2007).Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res, 168, 1-64. https://doi.org/10.1667/RR0763.1
- Paganetti H, Athar BS, Moteabbed M, et al (2012). Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field . Phys Med Biol, 57, 6047-61. https://doi.org/10.1088/0031-9155/57/19/6047
- Statistic of breast cancer in India: Global Comparison [Internet]. Available from: http://www.breastcancerindia.net/statistics/stat_global.html, Last accessed on 2016 Feb 16.
- Stovall M, Smith SA, Langholz BM, et al (2008). Dose to the contralateral breast from RT and risk of second primary breast cancer. Int J Radiat Oncol Biol Phys, 72, 1021-30. https://doi.org/10.1016/j.ijrobp.2008.02.040
- Schneider U, Sumila M, Robotka J, et al (2011). Dose-response relationship for breast cancer induction at radiotherapy dose. Int J Radiat Oncol Biol, 6.
- Schneider U, Zwahlen D, Ross D, Kaser-Hotz B (2005). Estimation of radiation induced cancer from three dimensional dose distributions :concept of organ equivalent dose. Int J Radiat Oncol Biol Phys, 61, 1510-5. https://doi.org/10.1016/j.ijrobp.2004.12.040
- Schneider U, Kaser-Hotz B (2005). Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys, 44, 235-9. https://doi.org/10.1007/s00411-005-0016-1
- Swerdlow AJ, Barber JA, Hudson GV, et al (2000). Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol, 18, 498-509. https://doi.org/10.1200/JCO.2000.18.3.498
- Walsh L, Ruhm W, Kellerer AM (2004). Cancer risk estimates for X-rays with regard to organ specific doses, part I: All solid cancers combined. Radiat Environ Biophys, 43, 145-51. https://doi.org/10.1007/s00411-004-0248-5
- Yoon M, Shin DH, Kim J, et al (2011).Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys, 81, 637-46. https://doi.org/10.1016/j.ijrobp.2010.06.039